A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

India approves AstraZeneca’s Dapagliflozin for diabetes patients with chronic kidney disease; the drug significantly reduces risk of sustained estimated glomerular filtration rate, cardiovascular deaths, hospitalizations due to heart failure

Global drug delivery devices market expected to hit US$124.8B by 2029, with CAGR growth of 5.6% from 2022-2029 driven by increase in chronic diseases, including diabetes; diabetes expected to affect 783 million people worldwide by 2045

GlobalData: Continuous glucose monitoring devices could become main solution for US diabetes population if FDA's proposed changes to reimbursement go ahead; majority of diabetes patients currently have to undergo invasive self-testing several times a day

Studies find cinnamon extracts carry antimicrobial properties, contribute to slow down of nervous system degeneration, can regulate blood glucose; cinnamon is used to support health of patients with HIV, Alzheimer's, Multiple Sclerosis and diabetes

FDA approves Provention Bio's Tzield teplizumab-mzwv injectable, the first drug approved to delay onset of stage 3 type 1 diabetes in adults, children 8 years and older; drug carries price of US$193,900 for 14-day treatment

Ask us about our Transformation & Innovation market view

Trending Chart

Interactive chart with headline count